Patent Application for Treating Disease with Dichlorphenamide
Summary
The USPTO has published a patent application (US20260083692A1) from Strongbridge Dublin Limited for methods of treating disease using dichlorphenamide in conjunction with an organic anion transporter-1 (OAT1) substrate. The application details methods for administering the compounds and monitoring patient response and toxicity.
What changed
This document is a published patent application from the USPTO detailing a novel method for treating diseases. The application, filed by Strongbridge Dublin Limited, describes administering dichlorphenamide alongside an organic anion transporter-1 (OAT1) substrate, with a focus on monitoring for toxicity and clinical response.
While patent applications do not impose direct regulatory obligations on companies, they signal potential future drug development and intellectual property claims in the pharmaceutical sector. Compliance officers in the pharmaceutical industry should be aware of such filings as they can indicate emerging therapeutic approaches and potential future market exclusivity for specific treatments.
Archived snapshot
Mar 26, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
METHODS OF TREATING DISEASE WITH DICHLORPHENAMIDE
Application US20260083692A1 Kind: A1 Mar 26, 2026
Assignee
Strongbridge Dublin Limited
Inventors
Fredric Jay COHEN
Abstract
Provided herein are methods for administering dichlorphenamide, or a pharmaceutically acceptable salt thereof, to a subject in need thereof, wherein the subject is also being administered an organic anion transporter-1 (OAT1) substrate to treat an associated disease or disorder. The method comprises administering to the subject a therapeutically effective amount of dichlorphenamide, or a pharmaceutically acceptable salt thereof, and monitoring the subject for signs and symptoms of toxicity and clinical response associated with the OAT1 substrate.
CPC Classifications
A61K 31/18 A61K 45/06 A61P 3/12 G01N 33/5014
Filing Date
2025-10-17
Application No.
19361331
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Pharma (A61K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Pharma (A61K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.